Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2009 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (185)	2/12/2009 3:34:33 PM
From: Biomaven	Respond to of 418

I saw a poster that showed similar PK in monkeys with a subq pump than with an infusion pump, and maybe they could even get away with daily subq injections. Obviously a switch would require new trials and cause delay, but conceivably could be done in parallel. But at the end of the day, if they can continue to show dramatic efficacy I'm not sure this issue will matter that much. If they can only show decent efficacy, then maybe it would be enough to kill it. Peter